Figure 1.

Flow chart. HSCT = hematopoietic stem cell transplant. Relapse is determined by the medical team through pathology reports. With relapse, most patients return to active treatment and their issues change dramatically relative to those in recovery. Because they also usually withdraw from quality of life research at this point, this protocol withdrew patients and spouses from the study at the time of relapse. Spouses were withdrawn when their patients died. Due to the high mortality and morbidity rates associated with HSCT, sample sizes naturally fluctuated over time.